ROYAL BANK OF CANADA

Bank

Position in GMAB — Genmab A/S

CIK 1000275 TORONTO, A6

Back to GMAB Full portfolio

Position in GMAB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,028,120

-$514,816 QoQ

Shares Held

150,135

+1.8% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 89.742565024811.ToString("F0")% Shared 9.177073966763247.ToString("F0")% None 1.0803610084257502.ToString("F0")%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. GMAB ranks #32 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,111,871	$496,494,870
2	IONS	Ionis Pharmaceuticals Inc	3,801,815	$285,478,282
3	REGN	Regeneron Pharmaceuticals, Inc.	351,171	$271,328,756
4	ALNY	Alnylam Pharmaceuticals, Inc.	791,515	$261,888,563
5	INCY	Incyte Corp	1,054,123	$99,214,053
6	INSM	INSMED Inc	523,101	$85,537,473
7	MRNA	Moderna, Inc.	999,340	$50,766,470
8	HALO	Halozyme Therapeutics, Inc.	658,290	$42,545,279

All Filings in GMAB

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,028,120	150,135	+1.8%	Shares	Defined	2026-05-15
2025-12-31	$4,542,936	147,498	+27.1%	Shares	Defined	2026-02-17
2025-09-30	$3,560,539	116,092	-1.0%	Shares	Defined	2025-11-14
2025-06-30	$2,423,168	117,288	-2.7%	Shares	Defined	2025-11-21
2025-03-31	$2,360,661	120,565	-62.8%	Shares	Defined	2025-11-21
2024-12-31	$6,761,919	324,002	-59.4%	Shares	Defined	2025-02-14
2024-09-30	$19,450,676	797,813	+0.6%	Shares	Defined	2024-11-14
2024-06-30	$19,921,904	792,754	+1.1%	Shares	Defined	2024-11-06
2024-03-31	$23,460,563	784,372	+22.4%	Shares	Defined	2024-11-05
2023-12-31	$20,409,087	640,989	-23.3%	Shares	Defined	2024-02-14
2023-09-30	$29,479,015	835,810	+16.6%	Shares	Defined	2023-11-14
2023-06-30	$27,254,992	717,048	+18.6%	Shares	Defined	2023-08-14
2023-03-31	$22,829,164	604,586	+1.0%	Shares	Defined	2023-05-15
2022-12-31	$25,373,793	598,721	-12.5%	Shares	Defined	2023-02-14
2022-09-30	$21,994,908	684,560	-7.8%	Shares	Defined	2022-11-14
2022-06-30	$24,123,821	742,500	+10.8%	Shares	Defined	2022-08-15
2022-03-31	$24,243,527	670,081	+3.9%	Shares	Defined	2022-05-16
2021-12-31	$25,519,560	645,085	+3.5%	Shares	Defined	2022-02-14
2021-09-30	$27,239,517	623,330	+6.6%	Shares	Defined	2021-11-15
2021-06-30	$23,875,133	584,745	+10.3%	Shares	Defined	2021-08-16
2021-03-31	$17,410,566	530,325	-9.8%	Shares	Defined	2021-07-20
2020-12-31	$23,892,910	587,627	+10.3%	Shares	Defined	2021-02-16
2020-09-30	$19,511,076	532,944	+14.5%	Shares	Defined	2020-11-16
2020-06-30	$15,770,606	465,347	-7.0%	Shares	Defined	2020-08-14
2020-03-31	$10,608,389	500,632	—	Shares	Defined	2020-06-16
No filing history on record for this holder in this stock.